Xiaopan Cai

1.5k total citations
35 papers, 1.2k citations indexed

About

Xiaopan Cai is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Biomedical Engineering. According to data from OpenAlex, Xiaopan Cai has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Biomedical Engineering. Recurrent topics in Xiaopan Cai's work include Sarcoma Diagnosis and Treatment (9 papers), Nanoplatforms for cancer theranostics (9 papers) and Bone Tumor Diagnosis and Treatments (8 papers). Xiaopan Cai is often cited by papers focused on Sarcoma Diagnosis and Treatment (9 papers), Nanoplatforms for cancer theranostics (9 papers) and Bone Tumor Diagnosis and Treatments (8 papers). Xiaopan Cai collaborates with scholars based in China, United States and Hong Kong. Xiaopan Cai's co-authors include Jianru Xiao, Yiyun Cheng, Quan Huang, Jingjing Hu, Xinyu Wang, Qiang Zhang, Lin Li, Xin Gao, Qiang Zhang and Fei Wang and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Biomaterials.

In The Last Decade

Xiaopan Cai

34 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaopan Cai China 17 572 491 384 226 198 35 1.2k
Yilun Wu China 19 540 0.9× 380 0.8× 426 1.1× 266 1.2× 275 1.4× 44 1.4k
Gaizhen Kuang China 20 701 1.2× 319 0.6× 496 1.3× 123 0.5× 240 1.2× 42 1.2k
Tianyuan Ci China 25 713 1.2× 455 0.9× 799 2.1× 217 1.0× 126 0.6× 43 1.8k
Bo Lü China 24 532 0.9× 862 1.8× 746 1.9× 331 1.5× 281 1.4× 74 2.1k
Wei‐Yun Lai Taiwan 18 287 0.5× 500 1.0× 208 0.5× 167 0.7× 141 0.7× 29 1.1k
Zhengjie Zhou China 17 713 1.2× 374 0.8× 356 0.9× 97 0.4× 252 1.3× 33 1.2k
Dayun Yang China 22 620 1.1× 457 0.9× 337 0.9× 151 0.7× 260 1.3× 33 1.3k
Xiaofei Liang China 20 462 0.8× 488 1.0× 410 1.1× 155 0.7× 269 1.4× 52 1.3k
Açelya Yılmazer Türkiye 21 772 1.3× 584 1.2× 171 0.4× 186 0.8× 512 2.6× 64 1.8k

Countries citing papers authored by Xiaopan Cai

Since Specialization
Citations

This map shows the geographic impact of Xiaopan Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaopan Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaopan Cai more than expected).

Fields of papers citing papers by Xiaopan Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaopan Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaopan Cai. The network helps show where Xiaopan Cai may publish in the future.

Co-authorship network of co-authors of Xiaopan Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaopan Cai. A scholar is included among the top collaborators of Xiaopan Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaopan Cai. Xiaopan Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Shaohui, Jun Chen, Yan Fang Liu, et al.. (2025). Deep learning algorithms from histopathological images stratify molecular subtypes for leiomyosarcoma: a proof-and-concept diagnostic study. International Journal of Surgery. 111(9). 5959–5969.
2.
Li, Lin, Guangyu Rong, Xīn Gào, et al.. (2024). Bone‐Targeted Fluoropeptide Nanoparticle Inhibits NF‐κB Signaling to Treat Osteosarcoma and Tumor‐Induced Bone Destruction. Advanced Science. 12(1). e2412014–e2412014. 4 indexed citations
3.
He, Shaohui, Haitao Sun, Jian Yang, et al.. (2022). Surgical efficacy and survival prediction of patients with unspecified malignant bone tumors. BMC Cancer. 22(1). 1078–1078. 6 indexed citations
4.
Wang, Yao, et al.. (2021). Real-world experience with management of spinal ganglioneuroma: long-term follow-up observations of 31 cases. European Spine Journal. 30(10). 2896–2905. 4 indexed citations
5.
Gao, Xin, Lin Li, Xiaopan Cai, et al.. (2020). Targeting nanoparticles for diagnosis and therapy of bone tumors: Opportunities and challenges. Biomaterials. 265. 120404–120404. 145 indexed citations
6.
Wang, Tao, Jian Yang, Wen Guo, et al.. (2020). Treatment strategies and outcomes for spinal rhabdomyosarcoma: A series of 11 cases in a single center and review of the literature. Clinical Neurology and Neurosurgery. 192. 105729–105729. 5 indexed citations
7.
Zhao, Chenglong, Xiaopan Cai, Yao Wang, et al.. (2020). NAT1 promotes osteolytic metastasis in luminal breast cancer by regulating the bone metastatic niche via NF-κB/IL-1B signaling pathway.. PubMed. 10(8). 2464–2479. 14 indexed citations
8.
Zhao, Yuechao, Shaohui He, Haitao Sun, et al.. (2019). Symptomatic aneurysmal bone cysts of the spine: clinical features, surgical outcomes, and prognostic factors. European Spine Journal. 28(6). 1537–1545. 9 indexed citations
9.
Gao, Xin, Qi Jia, Xiaopan Cai, et al.. (2019). Recurrence or neurological loss? Resection mode selection for patients with large sacral chordoma: an analysis of prognostic factors and quality of life. Acta Neurochirurgica. 161(12). 2433–2441. 6 indexed citations
10.
Wang, Tao, Qi Jia, Xin Gao, et al.. (2019). Secondary aneurysmal bone cyst of the spine: Clinicopathological features, surgical modalities and outcomes. Clinical Neurology and Neurosurgery. 188. 105595–105595. 7 indexed citations
11.
Zhou, Zhengjie, Tianqi Fan, Yan Yang, et al.. (2018). One stone with two birds: Phytic acid-capped platinum nanoparticles for targeted combination therapy of bone tumors. Biomaterials. 194. 130–138. 65 indexed citations
12.
Wang, Yitong, Quan Huang, Xiao He, et al.. (2018). Multifunctional melanin-like nanoparticles for bone-targeted chemo-photothermal therapy of malignant bone tumors and osteolysis. Biomaterials. 183. 10–19. 123 indexed citations
13.
Hu, Jingjing, et al.. (2018). A pH-responsive hydrogel with potent antibacterial activity against both aerobic and anaerobic pathogens. Biomaterials Science. 7(2). 581–584. 72 indexed citations
14.
Yang, Jian, Qi Jia, Wei Wan, et al.. (2017). Surgical treatment of upper cervical spine metastases: a retrospective study of 39 cases. World Journal of Surgical Oncology. 15(1). 21–21. 25 indexed citations
15.
Cai, Xiaopan, Haifeng Wei, Xinghai Yang, et al.. (2017). miR-215 suppresses proliferation and migration of non-small cell lung cancer cells. Oncology Letters. 13(4). 2349–2353. 23 indexed citations
16.
Zhao, Chenglong, Xin Gao, Jian Yang, et al.. (2017). Surgical management and outcome of spinal alveolar soft part sarcoma (ASPA): a case series of five patients and literature review. World Journal of Surgical Oncology. 15(1). 39–39. 2 indexed citations
17.
Yang, Jian, Xinghai Yang, Qi Jia, et al.. (2016). Spine extra-osseous chordoma mimicking neurogenic tumors: report of three cases and review of the literatures. World Journal of Surgical Oncology. 14(1). 206–206. 12 indexed citations
18.
Yang, Xinghai, Lei Li, Quan Huang, et al.. (2015). Wnt signaling through Snail1 and Zeb1 regulates bone metastasis in lung cancer.. PubMed Central. 5(2). 748–55. 43 indexed citations
19.
Cai, Xiaopan, Jingjing Hu, Jianru Xiao, & Yiyun Cheng. (2013). Dendrimer and cancer: a patent review (2006 – present). Expert Opinion on Therapeutic Patents. 23(4). 515–529. 29 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yilun Wu Breakdown of academic impact, for papers by Gaizhen Kuang Breakdown of academic impact, for papers by Tianyuan Ci Breakdown of academic impact, for papers by Bo Lü Breakdown of academic impact, for papers by Wei‐Yun Lai Breakdown of academic impact, for papers by Zhengjie Zhou Breakdown of academic impact, for papers by Dayun Yang Breakdown of academic impact, for papers by Xiaofei Liang Breakdown of academic impact, for papers by Açelya Yılmazer
Rankless by CCL
2026